AbbVie Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AbbVie Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • AbbVie Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $3.83B, a 68% increase year-over-year.
  • AbbVie Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $13.8B, a 8.25% decline year-over-year.
  • AbbVie Inc. annual Operating Income (Loss) for 2023 was $12.8B, a 29.6% decline from 2022.
  • AbbVie Inc. annual Operating Income (Loss) for 2022 was $18.1B, a 1.08% increase from 2021.
  • AbbVie Inc. annual Operating Income (Loss) for 2021 was $17.9B, a 57.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.8B $3.83B +$1.55B +68% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $12.3B $4B -$515M -11.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $12.8B $2.8B +$30M +1.08% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $12.8B $3.2B -$2.31B -41.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $15.1B $2.28B -$2.32B -50.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $17.4B $4.51B +$1.22B +37% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $16.2B $2.77B -$1.95B -41.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $18.1B $5.5B +$428M +8.44% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $17.7B $4.6B +$297M +6.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $17.4B $3.3B -$1.15B -25.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $18.5B $4.72B +$614M +15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $17.9B $5.07B +$1.32B +35.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $16.6B $4.31B +$1.05B +32.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $15.6B $4.44B +$3.69B +491% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $11.9B $4.1B +$500M +13.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $11.4B $3.75B -$203M -5.13% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $11.6B $3.26B +$638M +24.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $10.9B $752M -$2.65B -77.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $13.6B $3.6B +$593M +19.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $13B $3.96B +$6.4B Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $6.59B $2.62B -$542M -17.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $7.13B $3.4B +$638M +23.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $6.49B $3.01B +$107M +3.69% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $6.38B -$2.44B -$4.22B -237% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $10.6B $3.16B +$465M +17.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $10.1B $2.76B +$100M +3.76% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $10B $2.9B +$496M +20.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $9.55B $1.78B -$532M -23% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $10.1B $2.69B +$333M +14.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $9.74B $2.66B +$275M +11.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $9.47B $2.41B +$129M +5.66% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $9.34B $2.31B +$201M +9.51% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $9.14B $2.36B +$476M +25.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $8.66B $2.39B +$535M +28.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $8.13B $2.28B +$591M +35% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $7.54B $2.11B +$2.53B Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $5.01B $1.89B +$925M +96.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $4.08B $1.85B +$337M +22.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $3.75B $1.69B +$336M +24.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $3.41B -$415M -$1.95B -127% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $5.36B $960M -$411M -30% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $5.77B $1.52B +$62M +4.27% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $5.71B $1.35B +$46M +3.53% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $5.66B $1.54B -$286M -15.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $5.95B $1.37B -$225M -14.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $6.18B $1.45B +$31M +2.18% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $6.14B $1.31B +$327M +33.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $5.82B $1.82B Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $1.6B Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.42B Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $978M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.